Онкология

[Наталья П.]

Онкология

Просьба приводить краткое описание ресурсов

[Dr.Vad]

Подборка гайдлайнов по лечению онкопатологии (включая и онкогематологию) от NCCN Clinical Practice Guidelines in Oncology (ПДФ-презентации)

Guidelines for Treatment of Cancer by Site
Guidelines for Detection, Prevention and Risk Reduction
Guidelines for Supportive Care

[Ссылки доступны только зарегистрированным пользователям ]

[Наталья П.]

[Ссылки доступны только зарегистрированным пользователям ]
The Swedish Council on Technology Assessment in Health Care

Manual Lymph Drainage Combined With Compression Therapy for Arm Lymphedema Following Breast Cancer Treatment

Aromatase Inhibitors in Breast CancerComputed tomography in screening for lung cancer

Tumor vaccination

Radiotherapy for cancer

BNCT - Radiotherapy with neutrons for brain tumors

Stem cell transplantation for metastasized kidney cancer

Trastuzumab (herceptin) for metastasized breast cancer

Photodynamic therapy for skin cancer

Human papillomavirus testing in primary cervical cancer screening

Screening for colorectal cancer

Screening for colorectal cancer

[Tanya_M]

[Ссылки доступны только зарегистрированным пользователям ]
[Ссылки доступны только зарегистрированным пользователям ]
[Ссылки доступны только зарегистрированным пользователям ]
[Ссылки доступны только зарегистрированным пользователям ]

[Dr. Makhotin]

[Ссылки доступны только зарегистрированным пользователям ]
Сайт Kidney Cancer Association.
The organization of patients, families, doctors, and health professionals involved in kidney cancer.

[Наталья П.]

Memorial Sloan-Kettering Cancer Center (один из самых престижных и успешных научных институтов США, один из крупнейших мировых центров по изучению рака.
[Ссылки доступны только зарегистрированным пользователям ]
Ресурсы для специалистов и пациентов по лечению, диагностике и обучению в области онкологии.

Алфавитный указатель "альтернативных методов".
[Ссылки доступны только зарегистрированным пользователям ]
CA: a cancer journal for clinicians oпубликовал целую серию обзоров по сомнительным методам лечения. Особенно интересно читать как зарождался тот или иной метод и кто за ним стоял... отпадают всякие сомнения...

Questionable methods of cancer management: electronic devices.
CA Cancer J Clin. 1994 Mar-Apr;44(2):115-27. Review.

Questionable methods of cancer management: 'nutritional' therapies.
CA Cancer J Clin. 1993 Sep-Oct;43(5):309-19. Review.

Questionable methods of cancer management: the Committee for Freedom of Choice in Medicine, Inc.
CA Cancer J Clin. 1993 Mar-Apr;43(2):117-23.

Questionable methods of cancer management: Cancell/Entelev.
CA Cancer J Clin. 1993 Jan-Feb;43(1):57-62.

Questionable methods of cancer management: hydrogen peroxide and other 'hyperoxygenation' therapies.
CA Cancer J Clin. 1993 Jan-Feb;43(1):47-56.

Questionable methods of cancer management. Immuno-augmentative therapy (IAT).
CA Cancer J Clin. 1991 Nov-Dec;41(6):357-64.
__________________
E.E. Студенцов
Albert Einstein College of Medicine

Частичный перевод некоторых ресурсов
http://www.forums.rusmedserv.com/sho...28&postcount=6

[nastassia]

сегодня случайно наткнулась. оч доступно
[Ссылки доступны только зарегистрированным пользователям ]

[Наталья П.]

[Ссылки доступны только зарегистрированным пользователям ]
Oncology

[Наталья П.]

ONIX - New Online Portal for Cancer Researchers
[Ссылки доступны только зарегистрированным пользователям ]

The National Cancer Research Institute's free online cancer research portal, ONIX, has launched to the public today. ONIX (ONcology Information eXchange) enables scientists and clinicians to search through and access international research data held online - to improve the flow of cancer research information between individuals, institutions and organisations.
The portal is free-to-use and uses powerful search technology - which significantly reduces the time it currently takes for scientists and clinicians to find cancer-related data and information across the spectrum of research from genomics to clinical trials. This reduces duplication of research effort across the globe and makes it easier for researchers to collaborate on similar studies. It will speed up the development of new
therapies, and could potentially improve prognosis and diagnosis. It provides a unique integrated research environment online - the gateway to cancer research.

Scientists and clinicians can simultaneously search through multiple cancer-related databases, and track the latest developments in the field - what research is being carried out by which researchers - and where. Most importantly, when users carry out a search on ONIX, they receive the search results in a clear usable format.
The demand for a system such as ONIX is greater than ever. In the last 10 years the amount of health-related data available in electronic format has ballooned due to the vast volumes of data generated by modern molecular research techniques.

The scale of this data and the fact that - to date - it has been stored in many different formats and locations has meant that it is almost impossible for individual researchers to use this information effectively.

Professor Sir Alex Markham, who has been leading the development of ONIX, on behalf of NCRI, said: "ONIX represents a major advance for cancer research in the UK. I urge all cancer researchers, whether basic scientists, clinical researchers or pre-clinical medical students, to register with ONIX, explore the system in depth and continue to use it over the coming months and years.


"Researchers can use it to pull out specific, relevant data from the haystack of information out there - really saving them valuable time. As a result researchers will be better connected with the latest projects, data and updates from institutions in the field of cancer. What you see now is just the beginning - the system will eventually become a one-stop resource for online cancer research."

ONIX will be further refined - driven by user feedback. The NCRI will continue to develop the system - by adding more content, including databases, information about cancer-related organisations and resources. And improved functionality of ONIX will enable researchers to do more with these resources and information.

An 'Intelligent' search feature is being developed which interprets the language used in search terms - called semantic searching. This enables researchers to find highly specific cancer-related information whilst eliminating irrelevant search results.

The NCRI Informatics project is collaborating with a number of UK projects including the National Cancer Intelligence Network (NCIN) and the NHS Connecting for Health Research Capability Programme (RCP). The collaboration will allow researchers to access electronic summaries of the data held by these organisations in a secure way - and with appropriate authorisation researchers will be able to access and retrieve protected data.

Professor Sir Kenneth Calman, chair of the NCRI, said: "The NCRI partners are pleased to support the launch and continued development of ONIX. The role of ONIX in connecting resources and information, and streamlining research supports the key principles of high-level coordination that the NCRI aims to achieve. I am optimistic that ONIX will provide a research tool of significant benefit to both cancer researchers and cancer patients alike."

For further information, please visit:
[Ссылки доступны только зарегистрированным пользователям ]

About the Oncology Information Exchange (ONIX)

The NCRI ONIX is an internet portal aimed at clinical cancer researchers, clinicians, bioinformaticians and health informaticians from both public and private sectors. It provides resources and information on all aspects of global cancer research - from genomics to clinical trials.
The initiative is managed by the National Cancer Research Institute (NCRI), through the NCRI Informatics Initiative, established in 2003, to ensure that all research data generated achieves impact and is put to maximum use by the cancer research community.
The Oncology Information Exchange is funded by the NCRI Partners and Industry.
The service will launch in summer 2009 and be further developed until at least March 2010.

About the NCRI
The National Cancer Research Institute (NCRI) was established in April 2001. It is a UK-wide partnership between the government, charity and industry which promotes co-operation in cancer research among the 21 member organisations for the benefit of patients, the public and the scientific community.

[Ссылки доступны только зарегистрированным пользователям ]

NCRI members are: the Association of the British Pharmaceutical Industry (ABPI); Association for International Cancer Research; Biotechnology and Biological Sciences Research Council; Breakthrough Breast Cancer; Breast Cancer Campaign; Cancer Research UK; CHILDREN with LEUKAEMIA, Department of Health; Economic and Social Research Council; Leukaemia Research; Ludwig Institute for Cancer Research; Macmillan Cancer Support; Marie Curie Cancer Care; Medical Research Council; Northern Ireland Health and Social Care (Research & Development Office); Roy Castle Lung Cancer Foundation; Scottish Government Health Directorates (Chief Scientist Office); Tenovus; Welsh Assembly Government (Wales Office of Research and Development for Health &
Social Care); The Wellcome Trust; and Yorkshire Cancer Research.

[Наталья П.]

A Foundation for Evidence-Driven Practice:
A Rapid Learning System for Cancer Care

Workshop Summary

Sharon Murphy and Margie Patlak, Rapporteurs;

IOM (Institute of Medicine). 2010. Washington,DC: The National Academies Press

ISBN: 0-309-15127-9, 124 pages, 6 x 9, (2010)

Available online at: [Ссылки доступны только зарегистрированным пользователям ]


“…..Evidence of what is effective in clinical practice, especially evidence of what is appropriate for specific individual patients, is often lacking. In addition, if such evidence is available, it is often not translated rapidly into standard clinical practice, nor is it followed uniformly across healthcare practices. Our current healthcare system is plagued by overuse, underuse, and misuse, leading a recent Institute of Medicine (IOM) committee to conclude there is an urgent need to “know what works” (IOM, 2008).

This is problematic and challenging given the rapidity with which medical advances render standard care obsolete. A delay in translation or inappropriate care can shorten the life span of patients with life-threatening diseases.

Regrettably, much of the information that could improve care is not currently collected or distributed at the point of care, despite recent advances in information technology that make this possible….”

“…..There is a compelling public interest to advance the evidence base for cancer treatment and control measures, and to transform the way evidence is aggregated and applied in real-time, driving the process of discovery as a natural outgrowth of patient care, to ensure innovation, quality, safety, and value. A learning health care system for cancer would take full advantage of private and public sector databases and emerging information technology, including electronic medical records, to advance clinical cancer data, both as a public utility and a point-of-care patient-centered clinical decision support system. In light of substantial public investments in health information technology and comparative effectiveness research, this workshop is both timely and topical.



The promise of personalized cancer medicine and targeted therapies for cancer add further urgency to foster development of rapid learning systems to know what works and deliver higher value cancer care.

The goal of this workshop is to foster progress toward this vision for a rapid learning health care system for cancer. The workshop will examine the foundation stones upon which to build such a system and explore aspects of information technology which will enable such a system to operate seamlessly.

The impact on oncology providers and policy challenges will be examined with the aim of stimulating collaboration and action…”